ArticleVirology journal2026
Merkel cell polyomavirus DNA in CSF of paediatric patients with suspected meningitis or encephalitis.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe clinical significance of Merkel cell polyomavirus (MCPyV) in pediatric central nervous system (CNS) infections remains uncertain, particularly in immunocompromised children.
objectiveTo determine the frequency of MCPyV DNA in cerebrospinal fluid (CSF) from children with suspected viral meningitis or encephalitis and evaluate its association with HIV infection, CSF findings, and clinical outcomes.
methodsCSF samples from 46 pediatric patients with suspected viral CNS infection were analyzed using TaqMan probe-based quantitative PCR targeting the large T-antigen gene. Positive specimens were confirmed by amplification of an independent VP1 target and bidirectional Sanger sequencing following conventional PCR re-amplification. Clinical, laboratory, and outcome data were compared using appropriate statistical tests.
resultsMCPyV DNA was detected in 6/46 patients (13.0%), all of whom were HIV-positive (p = 0.001; sensitivity analysis excluding patients with unknown HIV status, p = 0.002). Four isolates belonged to genotype I and two to genotype IIc. Compared with MCPyV-negative patients, MCPyV-positive patients had higher CSF lymphocyte percentages (89% vs. 84%; p = 0.048), higher protein concentrations (79 vs. 68 mg/dL; p = 0.022), lower glucose concentrations (51 vs. 55 mg/dL; p = 0.038), and more frequent altered consciousness (83.3% vs. 37.5%; p = 0.039). EBV DNA co-detection was identified in one MCPyV-positive patient.
conclusionsMCPyV DNA was detected exclusively in HIV-positive children and was associated with inflammatory CSF abnormalities. These findings suggest a possible association between MCPyV detection, immunosuppression, and CNS inflammation but do not establish causality. Larger multicenter studies are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.